We allocate 10% of our annual sales revenue to research and development. Our achievements result from the latest scientific and technical data, cooperation with the most advanced R&D institutions, and the knowledge of our senior experts.

During development, we focus on patient needs and requirements. In that way, Krka’s innovations facilitate treatment and improve patient compliance. We develop new products in improved pharmaceutical forms, ensure additional strengths and improved production processes that reflect our responsibility towards the natural environment, our wider social community, and all Krka employees.

DVOSLOJNE TABLETE

BILAYER TABLETS


Two incompatible substances in one tablet. Dual therapy in a single dose.

More
ZDRAVILA S PODALJŠANIM SPROŠČANJEM

PROLONGED-RELEASE MEDICINES


Prolonged activity of the active ingredient. Single dose, all-day action.

More
INOVACIJA S TEHNOLOGIJO OSMOTSKE ČRPALKE

OSMOTIC-CONTROLLED RELEASE INNOVATION


Laser technology and osmosis. Constant release of the active ingredient from each tablet.

More
800+
experts
developing new products
270+
patents granted
across Europe and Asia
170+
new products
in development

Continue browsing

Multiparty banner 1

STATE-OF-THE-ART TECHNOLOGY

We ensure the high quality, safety and efficacy of our medicines with state-of-the-art technology.

More

QUALITY

We are committed to quality, as it is an essential part of everything we do.

More

PRODUCTS

We provide a safe and effective treatment with high-quality products.

More